The Society Honors Five Scientists for Outstanding Work in Blood Cancer Research

The Leukemia & Lymphoma Society has selected five researchers to receive its prestigious Stohlman Scholar Award, recognizing outstanding contributions to the advancement of blood cancer research. The awards will be officially announced at the Society's Stohlman Scholar Scientific Symposium in Dallas Nov. 2-3....
Read More...
[Source: Society News]

Blood Cancer Strikes Wisteria Lane

This season on ABC's Desperate Housewives, character Lynette Scavo's struggle with Hodgkin lymphoma is expected to raise awareness about the blood cancer. With more than 24 million viewers each episode, the show presents an outstanding opportunity to focus public attention on lymphoma and what science is doing to try to cure it....
Read More...
[Source: Society News]

Express Your Love for Mom with a Personalized Gift and Help Save Lives

Give your mother something she'll cherish this Mother's Day and give the gift of hope to thousands of patients battling cancer....
Read More...
[Source: Society News]

The Leukemia & Lymphoma Society Applauds Voluntary Agreement to Maintain Coverage for Cancer Patient Care Costs

Volunteers from The Leukemia & Lymphoma Society (LLS) were on hand today for the signing of an agreement among insurance companies operating in Florida to maintain coverage of routine patient care costs for patients enrolled in cancer clinical trials....
Read More...
[Source: Society News]

LLS's Chief Medical Officer Elected to the National Coalition for Cancer Research

Barton Kamen, M.D., Ph.D., chief medical officer, The Leukemia & Lymphoma Society, has been elected to the board of the prestigious, National Coalition for Cancer Research (NCCR)....
Read More...
[Source: Society News]

The Leukemia & Lymphoma Society� and Avila Therapeutics" Enter Partnership to Accelerate Development of AVL-292 For Patients with B Cell Malignancies

The Leukemia & Lymphoma Society (LLS) and Avila Therapeutics, Inc., today announced they have established a collaboration to support development of one of Avila's lead product candidates, AVL-292, for treatment of adults with B cell cancers....
Read More...
[Source: Society News]

May 2006 Commentary

This months topic is epigenetics, which refers to changes that stably alter gene activities without changing, or mutating, the DNA sequence of those genes. Like genetic mutations, we now know that epigenetic abnormalities can cause cancers, including blood cancers. And, as with cancer-causing mutations, laboratory and clinical studies are now showing that drugs that target specific epigenetic changes will be powerful treatments for blood cancer patients....
Read More...
[Source: Society News]